Literature DB >> 32334080

Efficient production of large deletion and gene fragment knock-in mice mediated by genome editing with Cas9-mouse Cdt1 in mouse zygotes.

Saori Mizuno-Iijima1, Shinya Ayabe2, Kanako Kato3, Shogo Matoba4, Yoshihisa Ikeda5, Tra Thi Huong Dinh3, Hoai Thu Le6, Hayate Suzuki7, Kenichi Nakashima8, Yoshikazu Hasegawa3, Yuko Hamada3, Yoko Tanimoto3, Yoko Daitoku3, Natsumi Iki3, Miyuki Ishida3, Elzeftawy Abdelaziz Elsayed Ibrahim3, Toshiaki Nakashiba9, Michito Hamada10, Kazuya Murata3, Yoshihiro Miwa3, Miki Okada-Iwabu11, Masato Iwabu11, Ken-Ichi Yagami3, Atsuo Ogura4, Yuichi Obata8, Satoru Takahashi10, Seiya Mizuno12, Atsushi Yoshiki9, Fumihiro Sugiyama3.   

Abstract

Genetically modified mouse models are essential for in vivo investigation of gene function and human disease research. Targeted mutations can be introduced into mouse embryos using genome editing technology such as CRISPR-Cas. Although mice with small indel mutations can be produced, the production of mice carrying large deletions or gene fragment knock-in alleles remains inefficient. We introduced the nuclear localisation property of Cdt1 protein into the CRISPR-Cas system for efficient production of genetically engineered mice. Mouse Cdt1-connected Cas9 (Cas9-mC) was present in the nucleus of HEK293T cells and mouse embryos. Cas9-mC induced a bi-allelic full deletion of Dmd, GC-rich fragment knock-in, and floxed allele knock-in with high efficiency compared to standard Cas9. These results indicate that Cas9-mC is a useful tool for producing mouse models carrying targeted mutations.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR; Cas9; Genetically engineered mouse model; Genome editing; Knock-in

Mesh:

Substances:

Year:  2020        PMID: 32334080     DOI: 10.1016/j.ymeth.2020.04.007

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  6 in total

1.  dsDNA-induced AIM2 pyroptosis halts aberrant inflammation during rhabdomyolysis-induced acute kidney injury.

Authors:  Chintogtokh Baatarjav; Takanori Komada; Tadayoshi Karasawa; Naoya Yamada; Ariunaa Sampilvanjil; Takayoshi Matsumura; Masafumi Takahashi
Journal:  Cell Death Differ       Date:  2022-06-23       Impact factor: 15.828

Review 2.  Designing libraries for pooled CRISPR functional screens of long noncoding RNAs.

Authors:  Carlos Pulido-Quetglas; Rory Johnson
Journal:  Mamm Genome       Date:  2021-09-17       Impact factor: 3.224

3.  The versatile electric condition in mouse embryos for genome editing using a three-step square-wave pulse electroporator.

Authors:  Kenta Nakano; Yukiko Shimizu; Tetsuya Arai; Taketo Kaneko; Tadashi Okamura
Journal:  Exp Anim       Date:  2021-12-07

4.  Detection of Indiscriminate Genetic Manipulation in Thoroughbred Racehorses by Targeted Resequencing for Gene-Doping Control.

Authors:  Teruaki Tozaki; Aoi Ohnuma; Kotono Nakamura; Kazuki Hano; Masaki Takasu; Yuji Takahashi; Norihisa Tamura; Fumio Sato; Kyo Shimizu; Mio Kikuchi; Taichiro Ishige; Hironaga Kakoi; Kei-Ichi Hirota; Natasha A Hamilton; Shun-Ichi Nagata
Journal:  Genes (Basel)       Date:  2022-09-04       Impact factor: 4.141

5.  Selective optogenetic activation of NaV1.7-expressing afferents in NaV1.7-ChR2 mice induces nocifensive behavior without affecting responses to mechanical and thermal stimuli.

Authors:  Toyoaki Maruta; Kotaro Hidaka; Satoshi Kouroki; Tomohiro Koshida; Mio Kurogi; Yohko Kage; Seiya Mizuno; Tetsuro Shirasaka; Toshihiko Yanagita; Satoru Takahashi; Ryu Takeya; Isao Tsuneyoshi
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

6.  DAJIN enables multiplex genotyping to simultaneously validate intended and unintended target genome editing outcomes.

Authors:  Akihiro Kuno; Yoshihisa Ikeda; Shinya Ayabe; Kanako Kato; Kotaro Sakamoto; Sayaka R Suzuki; Kento Morimoto; Arata Wakimoto; Natsuki Mikami; Miyuki Ishida; Natsumi Iki; Yuko Hamada; Megumi Takemura; Yoko Daitoku; Yoko Tanimoto; Tra Thi Huong Dinh; Kazuya Murata; Michito Hamada; Masafumi Muratani; Atsushi Yoshiki; Fumihiro Sugiyama; Satoru Takahashi; Seiya Mizuno
Journal:  PLoS Biol       Date:  2022-01-18       Impact factor: 8.029

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.